These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 16316723)
1. Chronic ecstasy (MDMA) use is associated with deficits in task-switching but not inhibition or memory updating executive functions. Dafters RI Drug Alcohol Depend; 2006 Jun; 83(2):181-4. PubMed ID: 16316723 [TBL] [Abstract][Full Text] [Related]
2. Impulsivity, inhibition and negative priming in ecstasy users. Dafters RI Addict Behav; 2006 Aug; 31(8):1436-41. PubMed ID: 16242244 [TBL] [Abstract][Full Text] [Related]
3. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes. Reay JL; Hamilton C; Kennedy DO; Scholey AB J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712 [TBL] [Abstract][Full Text] [Related]
5. Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds. Bedi G; Redman J Psychol Med; 2008 Sep; 38(9):1319-30. PubMed ID: 18226286 [TBL] [Abstract][Full Text] [Related]
6. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol. Indlekofer F; Piechatzek M; Daamen M; Glasmacher C; Lieb R; Pfister H; Tucha O; Lange KW; Wittchen HU; Schütz CG J Psychopharmacol; 2009 Jul; 23(5):495-509. PubMed ID: 18635709 [TBL] [Abstract][Full Text] [Related]
7. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study. de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910 [TBL] [Abstract][Full Text] [Related]
9. Cognitive performance in light current users and ex-users of ecstasy (MDMA) and controls. Golding JF; Groome DH; Rycroft N; Denton Z Am J Drug Alcohol Abuse; 2007; 33(2):301-7. PubMed ID: 17497553 [TBL] [Abstract][Full Text] [Related]
10. Executive functions and updating of the contents of working memory in unipolar depression. Harvey PO; Le Bastard G; Pochon JB; Levy R; Allilaire JF; Dubois B; Fossati P J Psychiatr Res; 2004; 38(6):567-76. PubMed ID: 15458852 [TBL] [Abstract][Full Text] [Related]
11. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users. Fox HC; McLean A; Turner JJ; Parrott AC; Rogers R; Sahakian BJ Psychopharmacology (Berl); 2002 Jul; 162(2):203-14. PubMed ID: 12110998 [TBL] [Abstract][Full Text] [Related]
12. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)]. Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451 [TBL] [Abstract][Full Text] [Related]
13. Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use. Gouzoulis-Mayfrank E; Fischermann T; Rezk M; Thimm B; Hensen G; Daumann J Drug Alcohol Depend; 2005 Jun; 78(3):317-23. PubMed ID: 15893163 [TBL] [Abstract][Full Text] [Related]
14. Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis. Verdejo-García AJ; López-Torrecillas F; Aguilar de Arcos F; Pérez-García M Addict Behav; 2005 Jan; 30(1):89-101. PubMed ID: 15561451 [TBL] [Abstract][Full Text] [Related]
15. Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users. Reneman L; Schilt T; de Win MM; Booij J; Schmand B; van den Brink W; Bakker O J Psychopharmacol; 2006 May; 20(3):389-99. PubMed ID: 16574713 [TBL] [Abstract][Full Text] [Related]
16. Evidence for selective executive function deficits in ecstasy/polydrug users. Fisk JE; Montgomery C J Psychopharmacol; 2009 Jan; 23(1):40-50. PubMed ID: 18515461 [TBL] [Abstract][Full Text] [Related]
17. Ecstasy-related deficits in the updating component of executive processes. Montgomery C; Fisk JE Hum Psychopharmacol; 2008 Aug; 23(6):495-511. PubMed ID: 18512857 [TBL] [Abstract][Full Text] [Related]
18. Visuo-spatial working memory deficits in current and former users of MDMA ('ecstasy'). Wareing M; Fisk JE; Murphy P; Montgomery C Hum Psychopharmacol; 2005 Mar; 20(2):115-23. PubMed ID: 15641126 [TBL] [Abstract][Full Text] [Related]
19. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress. Parrott AC J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474 [TBL] [Abstract][Full Text] [Related]
20. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective. Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]